Call: 1-800-887-8100

 

New here?
Please register
Already a member?
Sign in now

 
Starting COPAXONE(R) Choosing a Therapy Importance of Therapy Therapy Expectations

Share Print

COPAXONE® Injection Assistance

Personalized injection training from the start

Insurance FinancialIt’s important that you receive proper training before giving yourself the first injection, whether you’re just starting out or changing to COPAXONE®. With experience, each injection takes less than a minute.1

Please call Shared Solutions® at 1-800-887-8100 to set up free in-home training.

Injecting COPAXONE®

COPAXONE® is given by a subcutaneous injection that goes just beneath the skin. You can inject manually with the pre-filled syringe or with help from the autoject®2 for glass syringe.

2-1-2_autoject2syringe.jpg

COPAXONE® injection tips

  • Take your COPAXONE® out of the refrigerator at least 20 minutes before you inject, as it may be more comfortable to inject your COPAXONE® if it’s at room temperature
  • Try applying a warm compress to the injection site for 5 minutes before injecting. Be sure to heat the compress (according to the manufacturer’s instructions), and then place a cloth barrier between the heated pack and your skin. Remember not to use a heat pack in any area where sensation of temperature is impaired
  • Rotate your COPAXONE® injection sites every day to reduce the potential for injection site reactions and help keep your skin healthy
  • For more tips and injection information, download Your COPAXONE® Injection Guide

Think of COPAXONE® injections as your daily dose of empowerment helping you to fight relapsing-remitting multiple sclerosis.

Watch our online training videos below.

Video Title Shared Solutions® In-Home Training
Mike, on COPAXONE® for RRMS since 2005
Manual Injection Tips
Using the autoject®2 for glass syringe


Current rating: 3.9 (40 ratings)

References:
1. Data on file. Teva Neuroscience, Inc.
COP110006402/111826
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner

My recent articles

Social Relationships

Choosing a Therapy

Articles

Events & Patient Programs

master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.